Navigation überspringen
Universitätsbibliothek Heidelberg
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Fink, Christoph Andreas [VerfasserIn]   i
 Buchele, Carolin [VerfasserIn]   i
 Baumann, Lukas [VerfasserIn]   i
 Liermann, Jakob [VerfasserIn]   i
 Hoegen, Philipp [VerfasserIn]   i
 Ristau, Jonas [VerfasserIn]   i
 Regnery, Sebastian [VerfasserIn]   i
 Sandrini, Elisabetta [VerfasserIn]   i
 König, Laila [VerfasserIn]   i
 Rippke, Carolin [VerfasserIn]   i
 Bonekamp, David [VerfasserIn]   i
 Schlemmer, Heinz-Peter [VerfasserIn]   i
 Debus, Jürgen [VerfasserIn]   i
 Körber, Stefan A. [VerfasserIn]   i
 Klüter, Sebastian [VerfasserIn]   i
 Hörner-Rieber, Juliane [VerfasserIn]   i
Titel:Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer
Verf.angabe:Christoph A. Fink, Carolin Buchele, Lukas Baumann, Jakob Liermann, Philipp Hoegen, Jonas Ristau, Sebastian Regnery, Elisabetta Sandrini, Laila König, Carolin Rippke, David Bonekamp, Heinz-Peter Schlemmer, Juergen Debus, Stefan A. Koerber, Sebastian Klüter and Juliane Hörner-Rieber
E-Jahr:2024
Jahr:15 February 2024
Umfang:7 S.
Illustrationen:Illustrationen
Fussnoten:Gesehen am 27.05.2024
Titel Quelle:Enthalten in: Frontiers in oncology
Ort Quelle:Lausanne : Frontiers Media, 2011
Jahr Quelle:2024
Band/Heft Quelle:14(2024) vom: Feb., Artikel-ID 1308406, Seite 1-7
ISSN Quelle:2234-943X
Abstract:<sec><title>Background</title><p>Apart from superior soft tissue contrast, MR-guided stereotactic body radiation therapy (SBRT) offers the chance for daily online plan adaptation. This study reports on the comparison of dose parameters before and after online plan adaptation in MR-guided SBRT of localized prostate cancer.</p></sec><sec><title>Materials and methods</title><p>32 consecutive patients treated with ultrahypofractionated SBRT for localized prostate cancer within the prospective SMILE trial underwent a planning process for MR-guided radiotherapy with 37.5 Gy applied in 5 fractions. A base plan, derived from MRI simulation at an MRIdian Linac, was registered to daily MRI scans (predicted plan). Following target and OAR recontouring, the plan was reoptimized based on the daily anatomy (adapted plan). CTV and PTV coverage and doses at OAR were compared between predicted and adapted plans using linear mixed regression models.</p></sec><sec><title>Results</title><p>In 152 out of 160 fractions (95%), an adapted radiation plan was delivered. Mean CTV and PTV coverage increased by 1.4% and 4.5% after adaptation. 18% vs. 95% of the plans had a PTV coverage ≥95% before and after online adaptation, respectively. 78% vs. 100% of the plans had a CTV coverage ≥98% before and after online adaptation, respectively. The D<sub>0.2cc</sub> for both bladder and rectum were <38.5 Gy in 93% vs. 100% before and after online adaptation. The constraint at the urethra with a dose of <37.5 Gy was achieved in 59% vs. 93% before and after online adaptation.</p></sec><sec><title>Conclusion</title><p>Online adaptive plan adaptation improves target volume coverage and reduces doses to OAR in MR-guided SBRT of localized prostate cancer. Online plan adaptation could potentially further reduce acute and long-term side effects and improve local failure rates in MR-guided SBRT of localized prostate cancer.</p></sec>
DOI:doi:10.3389/fonc.2024.1308406
URL:kostenfrei: Volltext: https://doi.org/10.3389/fonc.2024.1308406
 kostenfrei: Volltext: https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1308406/full
 DOI: https://doi.org/10.3389/fonc.2024.1308406
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:daily adaptive radiotherapy
 Dosimetric benefits
 MR-guided radiotherapy
 prostate cancer
 stereotactic body radiation therapy
K10plus-PPN:1889915300
Verknüpfungen:→ Zeitschrift
 
 
Lokale URL UB: Zum Volltext

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69217669   QR-Code

zum Seitenanfang